N

Nichi-Iko Pharmaceutical Co Ltd
TSE:4541

Watchlist Manager
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Watchlist
Price: 0.0001 JPY Market Closed
Market Cap: 776 550.9T JPY
Have any thoughts about
Nichi-Iko Pharmaceutical Co Ltd?
Write Note
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Income Statement

184.4B
+0.7%
Revenue
Growth Rates:
1 Year
0%
3 Years
+5%
5 Years
+17%
7 Years
+37%
10 Years
-
-153.9B
-37%
Operating Income
Growth Rates:
1 Year
-965%
3 Years
-
5 Years
-
7 Years
-
10 Years
-
-145.2B
-38%
Net Income
Growth Rates:
1 Year
-668%
3 Years
-
5 Years
-
7 Years
-
10 Years
-

Earnings Waterfall
Nichi-Iko Pharmaceutical Co Ltd

Revenue
184.4B JPY
Cost of Revenue
-189.1B JPY
Gross Profit
-4.7B JPY
Operating Expenses
-149.2B JPY
Operating Income
-153.9B JPY
Other Expenses
8.7B JPY
Net Income
-145.2B JPY

Income Statement
Nichi-Iko Pharmaceutical Co Ltd

Rotate your device to view
Income Statement
Currency: JPY
Dec-2012 Mar-2013 Jun-2013 Sep-2013 Dec-2013 Mar-2014 Jun-2014 Sep-2014 Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022
Revenue
Revenue
71 863
N/A
93 927
+31%
95 374
+2%
97 573
+2%
100 443
+3%
103 623
+3%
109 435
+6%
115 045
+5%
121 104
+5%
127 021
+5%
131 670
+4%
135 059
+3%
139 481
+3%
143 513
+3%
146 493
+2%
149 677
+2%
152 468
+2%
149 263
-2%
154 161
+3%
157 172
+2%
158 004
+1%
164 716
+4%
164 067
0%
164 002
0%
165 923
+1%
166 591
+0%
170 836
+3%
175 763
+3%
181 528
+3%
190 074
+5%
188 816
-1%
188 186
0%
186 758
-1%
188 217
+1%
185 895
-1%
184 517
-1%
184 263
0%
179 058
-3%
183 177
+2%
184 378
+1%
Gross Profit
Cost of Revenue
(43 757)
(57 261)
(58 193)
(59 819)
(61 517)
(63 947)
(68 079)
(71 960)
(76 151)
(79 935)
(82 665)
(84 692)
(86 601)
(89 999)
(92 018)
(94 643)
(98 271)
(111 652)
(118 878)
(127 984)
(131 757)
(123 914)
(126 099)
(123 878)
(128 402)
(133 433)
(136 904)
(141 776)
(147 018)
(152 755)
(153 103)
(154 196)
(155 224)
(166 973)
(169 215)
(178 102)
(179 069)
(175 094)
(179 735)
(189 093)
Gross Profit
28 106
N/A
36 666
+30%
37 181
+1%
37 753
+2%
38 925
+3%
39 675
+2%
41 355
+4%
43 085
+4%
44 953
+4%
47 086
+5%
49 005
+4%
50 367
+3%
52 880
+5%
53 514
+1%
54 475
+2%
55 034
+1%
54 197
-2%
37 611
-31%
35 283
-6%
29 188
-17%
26 247
-10%
40 802
+55%
37 968
-7%
40 124
+6%
37 521
-6%
33 158
-12%
33 932
+2%
33 987
+0%
34 510
+2%
37 319
+8%
35 713
-4%
33 990
-5%
31 534
-7%
21 244
-33%
16 680
-21%
6 415
-62%
5 194
-19%
3 964
-24%
3 442
-13%
(4 715)
N/A
Operating Income
Operating Expenses
(21 535)
(28 433)
(28 848)
(29 476)
(30 816)
(32 292)
(33 592)
(35 009)
(36 137)
(37 467)
(38 810)
(39 342)
(39 886)
(40 845)
(41 939)
(44 142)
(45 942)
(30 807)
(27 152)
(24 429)
(18 041)
(30 501)
(30 639)
(27 800)
(26 731)
(24 936)
(26 013)
(26 707)
(27 397)
(34 446)
(34 082)
(34 371)
(35 534)
(21 136)
(21 187)
(20 856)
(20 440)
(114 014)
(115 917)
(149 153)
Selling, General & Administrative
(21 526)
(28 417)
(28 815)
(29 443)
(30 791)
(32 282)
(33 607)
(35 026)
(36 154)
(37 484)
(38 837)
(39 364)
(39 665)
(40 624)
(41 706)
(43 912)
(45 957)
(21 519)
(16 624)
(10 083)
(3 823)
(23 135)
(22 850)
(22 936)
(22 648)
(22 503)
(23 332)
(23 869)
(24 173)
(25 614)
(25 628)
(25 707)
(26 588)
(27 028)
(27 195)
(27 438)
(27 115)
(27 878)
(27 866)
(28 123)
Research & Development
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(1 130)
(1 976)
(3 252)
(4 466)
(4 556)
(4 405)
(3 811)
(3 502)
(3 570)
(3 687)
(3 859)
(4 261)
(3 749)
(4 040)
0
(3 275)
(3 289)
(3 214)
(4 028)
(4 247)
(5 172)
(4 655)
Depreciation & Amortization
3
3
0
0
0
0
0
0
0
0
0
0
(241)
(241)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other Operating Expenses
(13)
(20)
(34)
(32)
(24)
(9)
16
17
17
17
27
22
20
20
(233)
(230)
15
(9 288)
(9 398)
(12 370)
(10 966)
(2 900)
(3 233)
(459)
(272)
1 069
889
849
635
(4 571)
(4 705)
(4 624)
(8 946)
9 167
9 297
9 796
10 703
(81 889)
(82 879)
(116 375)
Operating Income
6 570
N/A
8 232
+25%
8 332
+1%
8 278
-1%
8 109
-2%
7 383
-9%
7 763
+5%
8 075
+4%
8 816
+9%
9 619
+9%
10 195
+6%
11 025
+8%
12 994
+18%
12 669
-3%
12 536
-1%
10 892
-13%
8 255
-24%
6 804
-18%
8 131
+20%
4 759
-41%
8 206
+72%
10 301
+26%
7 329
-29%
12 324
+68%
10 790
-12%
8 222
-24%
7 919
-4%
7 280
-8%
7 113
-2%
2 873
-60%
1 631
-43%
(381)
N/A
(4 000)
-950%
108
N/A
(4 507)
N/A
(14 441)
-220%
(15 246)
-6%
(110 050)
-622%
(112 475)
-2%
(153 868)
-37%
Pre-Tax Income
Interest Income Expense
(19)
9
(18)
(121)
(200)
(326)
(322)
(233)
(246)
(102)
(34)
(568)
3 371
2 977
2 436
2 798
(808)
(422)
94
232
(269)
(1 233)
(372)
(146)
(76)
676
(626)
(1 105)
(776)
(1 717)
(1 271)
(1 095)
(1 230)
960
1 471
1 516
2 145
2 210
4 046
4 770
Non-Reccuring Items
(69)
(202)
(455)
(65)
(137)
(4)
576
270
261
36
(235)
(242)
(539)
(302)
(75)
(11)
(1 139)
(419)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Gain/Loss on Disposition of Assets
(153)
(197)
(187)
(184)
(143)
(127)
(136)
(240)
(272)
(308)
(310)
(248)
(219)
(254)
(264)
(402)
(411)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Other Income
285
328
326
295
203
130
40
125
117
243
286
95
337
269
242
393
251
0
(4)
153
87
(2)
0
2
4
4
1 578
1 542
1 542
6 239
4 661
4 697
4 698
(1)
(2)
(3)
(4)
(1)
(1)
1
Pre-Tax Income
6 614
N/A
8 170
+24%
7 998
-2%
8 203
+3%
7 832
-5%
7 055
-10%
7 920
+12%
7 996
+1%
8 675
+8%
9 488
+9%
9 902
+4%
10 062
+2%
15 944
+58%
15 359
-4%
14 875
-3%
13 670
-8%
6 148
-55%
5 963
-3%
8 221
+38%
5 144
-37%
8 024
+56%
9 066
+13%
6 957
-23%
12 180
+75%
10 718
-12%
8 902
-17%
8 873
0%
7 718
-13%
7 879
+2%
7 395
-6%
5 021
-32%
3 221
-36%
(532)
N/A
1 067
N/A
(3 038)
N/A
(12 928)
-326%
(13 105)
-1%
(107 841)
-723%
(108 430)
-1%
(149 097)
-38%
Net Income
Tax Provision
(2 560)
(3 040)
(2 910)
(3 012)
(2 668)
(2 466)
(2 651)
(2 645)
(2 985)
(2 895)
(2 927)
(2 862)
(4 098)
(4 328)
(4 139)
(4 074)
(2 500)
(1 166)
(1 992)
(80)
390
(997)
141
(1 937)
(2 420)
(2 038)
(2 658)
(2 534)
(2 506)
(2 478)
(1 613)
(1 129)
(232)
(5 342)
(5 422)
(6 222)
(7 041)
2 190
2 275
3 028
Income from Continuing Operations
4 054
5 130
5 088
5 191
5 165
4 590
5 270
5 352
5 690
6 593
6 975
7 200
11 846
11 031
10 736
9 596
3 648
4 797
6 229
5 064
8 414
8 069
7 098
10 243
8 298
6 864
6 215
5 184
5 373
4 917
3 408
2 092
(764)
(4 275)
(8 460)
(19 150)
(20 146)
(105 651)
(106 155)
(146 069)
Income to Minority Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
66
108
216
202
181
158
92
209
227
476
667
749
863
Net Income (Common)
4 054
N/A
5 130
+27%
5 088
-1%
5 191
+2%
5 165
-1%
4 589
-11%
5 268
+15%
5 351
+2%
5 688
+6%
6 592
+16%
6 974
+6%
7 199
+3%
11 846
+65%
11 031
-7%
10 736
-3%
9 595
-11%
3 647
-62%
4 796
+32%
6 229
+30%
5 064
-19%
8 414
+66%
8 068
-4%
7 096
-12%
10 241
+44%
8 296
-19%
6 863
-17%
6 215
-9%
5 250
-16%
5 481
+4%
5 132
-6%
3 609
-30%
2 272
-37%
(606)
N/A
(4 179)
-590%
(8 246)
-97%
(18 917)
-129%
(19 665)
-4%
(104 982)
-434%
(105 405)
0%
(145 207)
-38%
EPS (Diluted)
79.49
N/A
100.59
+27%
99.76
-1%
101.78
+2%
93.91
-8%
208.59
+122%
87.8
-58%
89.18
+2%
94.8
+6%
109.87
+16%
116.23
+6%
119.98
+3%
197.43
+65%
183.85
-7%
185.1
+1%
168.33
-9%
63.98
-62%
82.69
+29%
111.23
+35%
90.43
-19%
150.25
+66%
141.54
-6%
124.49
-12%
175.08
+41%
134.77
-23%
109.71
-19%
96.81
-12%
82.01
-15%
85.65
+4%
80.29
-6%
56.32
-30%
35.5
-37%
-9.46
N/A
-65.19
-589%
-128.56
-97%
-287.69
-124%
-279.2
+3%
-1 496.64
-436%
-1 496.46
+0%
-2 060.87
-38%

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 210,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.